Investec Bank plc has filed a Form 8.5 public dealing disclosure relating to Advanced Medical Solutions Group Plc (AMS.L) under Rule 8.5 of the Takeover Code.
The disclosure confirms that Investec acted as an exempt principal trader with recognised intermediary status, dealing in a client-serving capacity during the relevant period.
Investec serves as Advisor and Joint Broker to Advanced Medical Solutions Group Plc, establishing its connected status to the offer party named in the filing.
The dealings were undertaken on 1st July 2026, with the formal disclosure submitted to the market on 2nd July 2026.
According to the filing, Investec purchased a total of 575,000 ordinary shares in Advanced Medical Solutions Group Plc during the dealing period.
The purchase prices ranged from a high of 280.5 pence per unit down to a lowest price of 280.1318 pence per unit across those transactions.
On the sell side, Investec recorded sales of 582,547 ordinary shares, with prices ranging from a high of 281 pence to a low of 279.75 pence per unit.
The filing confirms that no cash-settled derivative transactions, stock-settled derivative transactions, or options were involved in the disclosed dealings.
Investec also confirmed there are no indemnity arrangements, option agreements, or other formal or informal understandings relating to relevant securities that could constitute an inducement to deal or refrain from dealing.
Similarly, no agreements or understandings exist relating to voting rights or future acquisition or disposal of relevant securities tied to any derivative instrument.
The contact listed on the disclosure is Priyali Bhattacharjee, reachable by telephone in connection with the filing.
Public disclosures of this nature under Rule 8 of the Takeover Code are required to be made to a Regulatory Information Service to ensure full market transparency.
